Regulation of endogenous adenosine levels in the CNS: potential for therapy in stroke, epilepsy and pain.
Foster
A C
AC
Department of CNS Pharmacology, Gensia, Inc., San Diego, CA 92121, USA.
Miller
L P
LP
Wiesner
J B
JB
D000241:Adenosine / Q000378:metabolism* / Q000627:therapeutic use*; D000818:Animals; D002490:Central Nervous System / Q000502:physiology* / Q000503:physiopathology; D002493:Central Nervous System Diseases / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D004827:Epilepsy / Q000188:drug therapy* / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D018047:Receptors, Purinergic P1 / Q000502:physiology*
D018047:Receptors, Purinergic P1; D000241:Adenosine